Long-acting amylin analog peptide
Cagrilintide, explained in 60 seconds.
what it actually is, the research it shows up in, and the lab report behind the exact vial you'd get.
★ 4.9 from 2,598 verified researchers
for laboratory research use only · not for human or veterinary use
what is it? ↓so what is cagrilintide?
Cagrilintide is a synthetic long-acting analog of amylin, the pancreatic peptide co-secreted with insulin from beta cells. Its sequence is engineered for solubility and resistance to aggregation, and it carries a fatty-acid side chain that extends circulating half-life in pre-clinical systems, giving researchers a stable tool compound where native amylin is notoriously difficult to work with.
where it shows up
the research it appears in.
these are laboratory models, not claims about people. that distinction is the whole reason this is sold as a research compound.
here's the receipt.
every lot is screened by an independent lab and the report is published before you buy. the document below is a real published verve report — it's our BPC-157 lot, shown so you can see exactly what arrives with Cagrilintide: named lab, lot number, method, result.
pictured: verve's published BPC-157 report. your Cagrilintide lot ships with its own.
≥99%
spec
RP-HPLC
method
COA
per lot
the batch code on your vial matches a row in the COA library. if it doesn't match, the document isn't yours — that's the whole test.
same molecule. different paperwork.
“others” describes a general category of supplier, not any specific company or country.
what people ask.
Cagrilintide is a synthetic long-acting analog of the pancreatic peptide amylin, engineered for stability and extended half-life. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
researchers also look at
for laboratory research use only — not for human or veterinary use. verve makes no claims regarding the diagnosis, treatment, or prevention of any condition.